Tobias Banaschewski Selected Research

Conduct Disorder (Conduct Disorders)

12/2019	Distinct associations between fronto-striatal glutamate concentrations and callous-unemotional traits and proactive aggression in disruptive behavior.
7/2018	Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
7/2015	Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?
12/2012	Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
5/2010	Negative association between plasma cortisol levels and aggression in a high-risk community sample of adolescents.
3/2010	[Bipolar disorders as co-morbidity in childhood and adolescence--underdiagnosed or overinterpreted? Therapy of a 14-year-old boy with hyperkinetic conduct disorder and hypomania].
3/2003	Association of ADHD and conduct disorder--brain electrical evidence for the existence of a distinct subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Banaschewski Research Topics

Disease

109	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2004
11	Autism Spectrum Disorder 12/2021 - 11/2011
7	Conduct Disorder (Conduct Disorders) 12/2019 - 03/2003
6	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2013
6	Mental Disorders (Mental Disorder) 01/2020 - 01/2016
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 03/2016
5	Autistic Disorder (Autism) 01/2021 - 11/2011
5	Tic Disorders (Tic Disorder) 07/2018 - 07/2004
4	Alcoholism (Alcohol Abuse) 01/2021 - 05/2015
3	Schizophrenia (Dementia Praecox) 01/2022 - 05/2015
3	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021 - 09/2013
3	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 04/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 09/2015
2	Headache (Headaches) 01/2022 - 09/2013
2	Anorexia Nervosa 01/2022 - 02/2005
2	Hypersensitivity (Allergy) 12/2021 - 12/2015
2	Anxiety Disorders (Anxiety Disorder) 01/2015 - 06/2014
2	Tics (Tic) 07/2010 - 07/2006
1	Drug-Related Side Effects and Adverse Reactions 12/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 01/2022
1	Weight Gain 10/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2017
1	Pain (Aches) 01/2017
1	Cognitive Dysfunction 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2016
1	Dementia (Dementias) 03/2016
1	Anhedonia 12/2015
1	Oppositional Defiant Disorder 07/2015

Drug/Important Bio-Agent (IBA)

31	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 01/2004
21	Pharmaceutical PreparationsIBA 12/2022 - 01/2004
16	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022 - 01/2004
13	Lisdexamfetamine Dimesylate FDA Link 01/2020 - 09/2013
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
9	Biological ProductsIBA 01/2021 - 12/2008
7	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2017 - 03/2003
6	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 07/2004
4	Guanfacine (Tenex)FDA LinkGeneric 01/2022 - 10/2017
4	AmphetaminesIBA 01/2022 - 09/2012
4	Glutamic Acid (Glutamate)FDA Link 01/2021 - 11/2017
4	Antipsychotic Agents (Antipsychotics)IBA 07/2018 - 11/2004
4	ProdrugsIBA 12/2014 - 10/2013
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2022 - 03/2005
3	Clonidine (ST 155)FDA LinkGeneric 01/2022 - 03/2005
3	Amphetamine (Amfetamine)FDA LinkGeneric 07/2020 - 09/2013
3	ApolipoproteinsIBA 01/2017 - 01/2014
3	Apolipoproteins E (ApoE)IBA 01/2017 - 01/2014
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 09/2015 - 06/2014
3	Dopamine Receptors (Dopamine Receptor)IBA 08/2014 - 04/2008
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2014 - 04/2007
3	Serotonin (5 Hydroxytryptamine)IBA 11/2013 - 10/2008
2	Modafinil (Provigil)FDA Link 01/2022 - 10/2017
2	ORALIT (ORS)IBA 01/2022 - 01/2017
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 04/2008
2	Tiapride HydrochlorideIBA 07/2018 - 07/2004
2	Risperidone (Risperdal Consta)FDA LinkGeneric 07/2018 - 11/2004
2	A-factor (Streptomyces)IBA 07/2018 - 01/2018
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018 - 04/2012
2	Therapeutic UsesIBA 10/2017 - 09/2013
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2011 - 09/2009
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 05/2010 - 09/2009
2	3' Untranslated Regions (3' UTR)IBA 04/2008 - 04/2007
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 03/2005 - 01/2004
1	Insulin ReceptorIBA 01/2022
1	Sertraline (Zoloft)FDA LinkGeneric 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	MelatoninIBA 12/2021
1	TabletsIBA 12/2021
1	Polymethyl Methacrylate (Sol)IBA 11/2021
1	EndocannabinoidsIBA 01/2021
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	imidazoleacetic acid (IMAC)IBA 07/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018
1	BuffersIBA 11/2018
1	Biological FactorsIBA 10/2018
1	Excitatory Amino Acid AgentsIBA 05/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2017
1	Dexmethylphenidate Hydrochloride FDA LinkGeneric 10/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 03/2017
1	Adenosine Monophosphate (AMP)IBA 03/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2016
1	Memantine (Namenda)FDA Link 03/2016
1	Indicators and Reagents (Reagents)IBA 12/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2015
1	Inosine Monophosphate (IMP)IBA 11/2015

Therapy/Procedure

13	Therapeutics 07/2020 - 11/2004
12	Drug Therapy (Chemotherapy) 01/2021 - 09/2013
10	Neurofeedback 01/2022 - 11/2011
6	Combined Modality Therapy 08/2018 - 11/2004
3	Behavior Control 10/2020 - 06/2015
3	Psychology Biofeedback (Biofeedback) 03/2019 - 11/2011
2	Treatment Delay 01/2021 - 11/2019
2	Precision Medicine 01/2020 - 04/2013
2	Cognitive Training 01/2016 - 03/2013
2	Aftercare (After-Treatment) 07/2010 - 11/2009
1	Electrodes (Electrode) 07/2015